Transmission of human immunodeficiency virus type 1 resistant to nevirapine and zidovudine. Sydney Primary HIV Infection Study Group

The Journal of Infectious Diseases
A ImrieD A Cooper

Abstract

Human immunodeficiency virus type 1 (HIV-1) resistant to the nonnucleoside reverse transcriptase inhibitor nevirapine and to the nucleoside analogue zidovudine was transmitted from a homosexual man to his sex partner. The virus source patient had commenced combination zidovudine and nevirapine therapy 2.5 years prior to his partner's primary HIV infection. He received both therapies for 7 months, then discontinued nevirapine treatment, continuing to receive zidovudine monotherapy for a further 16 months. He had ceased zidovudine therapy 6 months before the time of his partner's seroconversion. Analysis of major and minor isolates obtained from both patients soon after onset of the recipient's primary HIV infection illness confirmed that an HIV-1 variant mutant at codons 70, 98, and 181 of the viral reverse transcriptase was transmitted. This is the first documented case of transmission of HIV-1 resistant to two antiretroviral compounds.

Citations

Feb 15, 2001·Journal of Medical Virology·M Pérez-OlmedaV Soriano
Nov 30, 2000·Current Infectious Disease Reports·G J Hanna, R T D'Aquila
Mar 12, 2004·International Journal of Antimicrobial Agents·M C ReUNKNOWN HIV-1 Emilia Romagna Infectious Disease Study Group
Feb 26, 2003·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Palanee AmmaranondAnthony D Kelleher
Aug 9, 2002·The New England Journal of Medicine·Susan J LittleDouglas D Richman
Mar 15, 2005·AIDS Care·Jennifer J HarmanBlair T Johnson
Sep 28, 1999·The Journal of Experimental Medicine·S J LittleD V Havlir
Jun 22, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·P R Harrigan, H C Côté
May 31, 2002·AIDS Research and Human Retroviruses·Victoria A LawsonDale A McPhee
Apr 15, 1999·AIDS·P L VernazzaM S Cohen
Jul 9, 1999·AIDS·R Rodríguez-RosadoV Soriano
Aug 15, 2003·Sexually Transmitted Diseases·Rachel C FlaksDavid L Cohn
Feb 19, 2010·HIV Medicine·B Kabamba-MukadiP Goubau
Sep 4, 1998·BMJ : British Medical Journal·D Pillay, M Zambon
Jan 30, 1999·Sexually Transmitted Infections·A L BallardD Pillay

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy & Infectious Diseases

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.